{
  "title": "Prognostic Impact of Clostridium butyricum MIYAIRI (CBM588) in Combination With Pembrolizumab for Advanced Urothelial Carcinoma: A Retrospective Cohort Study.",
  "pmid": "40765260",
  "doi": null,
  "affiliations": [
    "Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.",
    "Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.",
    "Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.",
    "Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.",
    "Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.",
    "Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.",
    "Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.",
    "Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.",
    "Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.",
    "Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan."
  ]
}